Federal Circuit Affirms that Medical Devices are Only Listable in the Orange Book if They Claim the Active Drug Ingredient

In the AIPLA Spring 2025 newsletter, Nath, Goldberg & Meyer ‘s Joshua Goldberg and Leia Dingott discuss how Court of Appeals for the Federal Circuit (CAFC) affirmed the decision by the U.S. District Court in New Jersey, which ordered the delisting of five U.S. Patents owned by TEVA on the ground “that the Inhaler Patents [...]

By |2025-05-08T14:23:15+00:00May, 2025|Governments|0 Comments

Updated United States Patent and Trademark Office Fee Schedule

On November 15, 2024, the United States Patent and Trademark Office (“USPTO”) announced that effective January 18, 2025, certain trademark filing fees are set to increase. The Final Rule is intended to “enable the USPTO to accomplish its mission to drive U.S. innovation, inclusive capitalism, and global competitiveness by delivering high-quality and timely trademark examination [...]

By |2024-11-27T18:56:46+00:00November, 2024|Uncategorized|0 Comments

Patent Disclosure Requirements and Consequences of Non Compliance

Joshua Goldberg of Nath, Goldberg & Meyer will be presenting the US Perspective regarding Patent Disclosure Requirements and Consequences of Non Compliance in a webinar on December 4, 2024. If you are interested in attending this Webinar with Joshua Goldberg, please sign up using the link below. https://shorowitzlaw.activetrail.biz/29102024-SHorowitz_IA_SHorowitz 

By |2024-11-22T19:46:04+00:00November, 2024|Webinar|0 Comments

“Orange Book Listings Should Not Include Medical Devices”

In a AIPPI article, Nath, Goldberg & Meyer 's Joshua Goldberg and Leia Dingott dissect the recent U.S. District Court of New Jersey Court ruling in a patent infringement dispute under the Hatch-Waxman Act, between Teva Branded Pharmaceutical Products R&D, Inc., et al. v. Amneal Pharmaceuticals LLC, et al. OPINION & ORDER denying 26 Plaintiff’s [...]

By |2024-09-24T22:24:13+00:00September, 2024|News|0 Comments

The Current Status of the Inherency Doctrine to Meet the Written Description Requirement for Negative Claim Limitations in the United States

Joshua Goldberg of Nath, Goldberg & Meyer enlightens us on the standard for satisfying the written description requirement for negative claim limitations. Although the inherency doctrine is available, it has been recently called into question. Now many wait to hear the if the Federal Circuit Court will decide to rehear the case en banc that [...]

By |2022-10-20T16:32:16+00:00October, 2022|Uncategorized|0 Comments

TRADEMARK MODERNIZATION ACT WILL HAVE SIGNIFICANT IMPACT ON U.S. TRADEMARK PRACTICE

The Trademark Modernization Act (TMA), going into effect December 18, 2021, will provide a faster and less expensive method to cancel trademark registrations based on non-use and abandonment. In addition, as of December 1, 2022, the deadline to respond to Office Actions for all non-Madrid based trademark applications will be three months, with a single [...]

By |2022-01-14T17:59:07+00:00November, 2021|Uncategorized|35 Comments

WHAT’S TAKING SO LONG AT THE U.S. TRADEMARK OFFICE?

Since Fall 2020, the U.S. Patent and Trademark Office (“USPTO”) has experienced an unprecedented surge in trademark filings from both U.S. and foreign applicants. The USPTO released a report in June 2021 stating that trademark filings at the USPTO increased roughly 63% over 2020, which translates to about 211,000 more applications. See:Director's Blog. This surge [...]

By |2022-01-14T17:59:38+00:00August, 2021|News|2 Comments
Go to Top